During November 1, 2002–June 18, 2003, a total of 8,465 probable
SARS cases were reported to WHO from 29 countries, including 75 from the United
States; 801 deaths (case-fatality proportion: 9.5%) have been reported, with
no SARS-related deaths reported from the United States.1 In
the United States, a total of 409 SARS cases have been reported from 42 states
and Puerto Rico, with 334 (82%) cases classified as suspect SARS and 75 (18%)
classified as probable SARS (i.e., more severe illnesses characterized by
the presence of pneumonia or acute respiratory distress syndrome).2 Serologic testing for antibody to SARS-associated
coronavirus (SARS-CoV) infection has been completed for 136 suspect and 45
probable cases. None of the suspect cases and eight (18%) of the probable
cases have demonstrated antibodies to SARS-CoV, all of which have been described
previously.3- 4 Of the eight
laboratory-confirmed SARS patients in the United States, seven had traveled
to areas with documented or suspected community transmission of SARS within
the 10 days before illness onset. Of these, four reported travel to Hong Kong
Special Administrative Region, China; two to Toronto, Canada; and one to both
Singapore and Taiwan. The remaining laboratory-confirmed SARS patient is the
spouse of a laboratory-confirmed SARS patient that had traveled to Hong Kong.